Lucid Diagnostics, Inc.
https://www.luciddx.com/
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Lucid Diagnostics, Inc.
Lucid Diagnostics Seeks Clear Path To US Reimbursement For Esophageal Precancer Test
Lishan Aklog, CEO of New York-based Lucid Diagnostics, has a long-term vision to provide the paradigm of prevention-to-treatment care for esophageal cancer. In the short term, the company anticipates a favorable outcome from an upcoming pivotal Medicare assessment of its early screening technology.
Scrip Asks…What Does 2024 Hold For Biopharma? Part 4: Transformative Technology
More than 75 industry executives and experts gazed into the crystal ball and shared with Scrip their predictions around transformative technologies. Perhaps unsurprisingly, AI was the dominant theme – but gene editing, cell therapies and new targeting modalities were also among the highlights.
Company Information
- Industry
-
Medical Devices
- Diagnostic Equipment & Supplies
-
In Vitro Diagnostics
- Cytology
- Molecular Diagnostics & Genetic Testing
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice